Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Anastasia

Pod24 and Cr30 Are Promising Surrogate Endpoints for Assessing the Outcome of Patients With Advanced Stage Follicular Lymphoma Enrolled in the Foll05 Trial by Fil.

Hematological Oncology

English

Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)

Hematological Oncology

English

Related publications

Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Hematological Oncology

English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology

Hematology

2018

English

Surrogate Endpoints in Advanced Sarcoma Trials: A Meta-Analysis

Oncotarget

Oncology

2018

English

Ncri Petrea Trial: A Phase 3 Evaluation of Pet-Guided, Response-Adapted Therapy in Patients With Previously Untreated, Advanced-Stage, High-Tumour-Burden Follicular Lymphoma

Hematological Oncology

English

Prm1 - Validation of Alternative “Surrogate” Clinical Endpoints in Advanced Melanoma

English

Characteristics and Treatments of Patients Enrolled in the CHAMP‐HF Registry Compared With Patients Enrolled in the PARADIGM‐HF Trial

Journal of the American Heart Association

Cardiovascular Medicine

Cardiology

2018

English

Pcn141 - Cost-Effectiveness Analysis of Obinutuzumab for the Treatment of Patients With Previously Untreated Advanced Follicular Lymphoma in Greece

English

Stratification of Patients With Follicular Lymphoma

2012

English

The Role of Surveillance Computed Tomography in Patients With Follicular Lymphoma

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Anastasia

Pod24 and Cr30 Are Promising Surrogate Endpoints for Assessing the Outcome of Patients With Advanced Stage Follicular Lymphoma Enrolled in the Foll05 Trial by Fil.

Clinical Characteristics of Patients With Negative Interim-Pet and Positive Final Pet: Data From the Prospective Pet-Oriented Hd0801 Study by Fondazione Italiana Linfomi (Fil)

Related publications

Outcome and Treatment of Relapsing Early Pet Negative Patients Included in the Eortc/Lysa/Fil H10 Trial on Stages I/Ii Hodgkin Lymphoma

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

Surrogate Endpoints in Advanced Sarcoma Trials: A Meta-Analysis

Ncri Petrea Trial: A Phase 3 Evaluation of Pet-Guided, Response-Adapted Therapy in Patients With Previously Untreated, Advanced-Stage, High-Tumour-Burden Follicular Lymphoma

Prm1 - Validation of Alternative “Surrogate” Clinical Endpoints in Advanced Melanoma

Characteristics and Treatments of Patients Enrolled in the CHAMP‐HF Registry Compared With Patients Enrolled in the PARADIGM‐HF Trial

Pcn141 - Cost-Effectiveness Analysis of Obinutuzumab for the Treatment of Patients With Previously Untreated Advanced Follicular Lymphoma in Greece

Stratification of Patients With Follicular Lymphoma

The Role of Surveillance Computed Tomography in Patients With Follicular Lymphoma